Executive pay
Revolution Medicines (RVMD) executive compensation
What Revolution Medicines, Inc. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.
- 2026 proxy statement
Mark A. Goldsmith, M.D., Ph.D. paid $14.7M (+46% on the year), pay ratio 34:1.
Filed Apr 27, 2026